CYP46A1 and Alzheimer disease: The researchers of these two meta-analyses investigated (a) the associations of CYP46A1 rs754203 or MTHFR rs1801133 polymorphisms with the risk of developing AD and (b) the confounding or interaction effect of ApoE ε4.